Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
JOYY ADR | YY | Dec 31, 2024 | 41.85 | +1.90 |
JP Morgan Chase | JPM | Dec 31, 2024 | 239.71 | +0.16 |
JP Morgan Chase & Co EE Pref | JPM-C | Dec 31, 2024 | 25.44 | +0.99 |
JP Morgan Chase & Co GG Pref | JPM-J | Dec 31, 2024 | 21.35 | +2.01 |
JP Morgan Chase & Co Ser DD Pref | JPM-D | Dec 31, 2024 | 25.17 | +1.57 |
JPMorgan Nasdaq Equity Premium Income ETF | JEPQ | Dec 31, 2024 | 56.38 | -1.49 |
Jumia Technologies ADR | JMIA | Dec 31, 2024 | 3.82 | -2.55 |
Junee Limited - Ordinary Shares | JUNE | Dec 31, 2024 | 3.75 | 0.00 |
Junior Gold Miners ETF Market Vectors | GDXJ | Dec 31, 2024 | 42.75 | +1.02 |
Juniper Networks | JNPR | Dec 31, 2024 | 37.45 | +0.27 |
Jupiter Neurosciences | JUNS | Dec 31, 2024 | 10.70 | 0.00 |
JVSPAC Acquisition | JVSAU | Dec 31, 2024 | 10.66 | 0.00 |
JVSPAC Acquisition | JVSA | Dec 31, 2024 | 10.42 | 0.00 |
JX Luxventure | JXJT | Dec 31, 2024 | 0.81 | 0.00 |
JX Luxventure | JXG | Dec 31, 2024 | 1.07 | 0.00 |
Kadant | KAI | Dec 31, 2024 | 344.99 | -0.19 |
Kairos Pharma | KAPA | Dec 31, 2024 | 1.52 | -2.56 |
Kairous Acquisition | KACL | Dec 31, 2024 | 12.33 | 0.00 |
Kaiser Aluminium | KALU | Dec 31, 2024 | 70.27 | +0.39 |
Kaival Brands Innovations Group | KAVL | Dec 31, 2024 | 0.91 | -16.95 |
Kaixin Holdings | KXIN | Dec 31, 2024 | 1.52 | -27.62 |
Kala Bio | KALA | Dec 31, 2024 | 6.94 | +1.02 |
Kaltura | KLTR | Dec 31, 2024 | 2.20 | 0.00 |
KalVista Pharmaceuticals | KALV | Dec 31, 2024 | 8.47 | +0.95 |
Kamada | KMDA | Dec 31, 2024 | 6.09 | +1.67 |
Kandi Technologies Group | KNDI | Dec 31, 2024 | 1.20 | +26.74 |
Kanzhun ADR | BZ | Dec 31, 2024 | 13.80 | +0.73 |
Karat Packaging | KRT | Dec 31, 2024 | 30.26 | +1.14 |
Karooooo | KARO | Dec 31, 2024 | 45.15 | -2.38 |
Kartoon Studios | TOON | Dec 31, 2024 | 0.59 | -8.67 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.